| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $145,872,515 ) (Continued on the next page) |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01NS125513 | Multiethnic Validation of VCID biomarkers in South Texas | 000 | 4 | NIH | 8/11/2025 | $949,277 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086777 | Prospective Health Impacts of Chronic Binge Eating Disorder in Hispanic Older Women Living with Food Insecurity (PROSPERA) | 000 | 2 | NIH | 6/18/2025 | $538,308 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG085545 | The role of sulfatide in the development of tauopathy in the context of ADRD | 000 | 2 | NIH | 5/29/2025 | $602,040 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG087907 | The pathogenic effects of senescent cells on their microenvironments and their role in human brain aging | 000 | 2 | NIH | 5/29/2025 | $206,994 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA285183 | Therapy-induced cognitive impairment in a rat model of prostate cancer | 000 | 3 | NIH | 7/14/2025 | $411,545 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS134868 | The Role of Dystrophin in Synapse Development | 000 | 2 | NIH | 7/28/2025 | $459,890 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG083865 | Vascular Imaging Biomarker Relationships to Alzheimer’s disease (VIBRA) | 000 | 2 | NIH | 7/7/2025 | $760,593 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UM1TR004538 | Institute for Integration of Medicine & Science: A Partnership to Improve Health | 000 | 3 | NIH | 8/7/2025 | $5,492,595 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01DK114920 | Spatial Multi-Omics to Profile Metabolic Pathways for Kidney Disease | 000 | 9 | NIH | 7/21/2025 | $823,813 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA264248 | Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model | 003 | 5 | NIH | 9/12/2025 | -$311,313 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA264248 | Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model | 002 | 5 | NIH | 9/8/2025 | $237,198 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA264248 | Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model | 001 | 5 | NIH | 9/4/2025 | $74,115 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA264248 | Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model | 000 | 5 | NIH | 9/3/2025 | $808,500 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R50CA265339 | Advancing Cancer Research Through Next Generation Sequencing at Mays Cancer Center of UT Health San Antonio | 000 | 4 | NIH | 8/21/2025 | $191,363 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32AG096998 | Circadian reprogramming in cellular senescence | 000 | 1 | NIH | 9/3/2025 | $75,052 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 Floyd Curl Drive | San Antonio | TX | 78229-3901 | BEXAR | USA | T2255345 | Dental Reimbursement Program | 00 | 1 | HRSA | 9/16/2025 | $48,824 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25AG095799 | Advancing cross-national research on aging and cognitive function: English/Spanish courses with the Mexican Health and Aging Study and HRS/HCAP global partner studies | 000 | 1 | NIH | 9/15/2025 | $372,904 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UC2AR082195 | Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD) | 000 | 2 | NIH | 9/8/2025 | $2,953,810 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30DK145169 | The Zone-Specific Metabolic Effects of Glucagon Receptor Agonism in the Treatment of Obesity and Metabolic Liver Disease | 001 | 1 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK141843 | Glucagon-mediated glycemic effect in humans with and without rerouted gut after bariatric surgery | 000 | 1 | NIH | 9/10/2025 | $775,865 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30DK145169 | The Zone-Specific Metabolic Effects of Glucagon Receptor Agonism in the Treatment of Obesity and Metabolic Liver Disease | 000 | 1 | NIH | 9/12/2025 | $39,750 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K08AG090815 | Bridging Gaps to Translate Plasma Alzheimer's Disease Biomarkers to Diverse Populations | 000 | 1 | NIH | 9/9/2025 | $163,080 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG096625 | Does extracellular tau modulate neurogenesis via LRP1? | 000 | 1 | NIH | 9/9/2025 | $433,125 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UC2AR082195 | Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD) | 001 | 2 | NIH | 9/9/2025 | $279,997 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 002 | 25 | NIH | 6/10/2025 | $721,482 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL175081 | Characterize TMEM94 as ER Mg2+ uptake machinery and pathophysiological consequences. | 000 | 1 | NIH | 7/31/2025 | $586,516 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA289167 | Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression | 001 | 2 | NIH | 5/22/2025 | $17,882 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA289167 | Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression | 000 | 2 | NIH | 3/3/2025 | $160,937 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 001 | 3 | NIH | 6/12/2025 | $52,858 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U19AG076581 | Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | 003 | 3 | NIH | 9/2/2025 | $806,739 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 3 | NIH | 3/3/2025 | $475,723 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U19AG076581 | Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | 002 | 3 | NIH | 8/29/2025 | $110,683 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U19AG076581 | Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | 001 | 3 | NIH | 8/26/2025 | $4,853,251 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 002 | 1 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 001 | 1 | NIH | 3/12/2025 | $0 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 000 | 1 | NIH | 3/12/2025 | $41,506 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 001 | 8 | NIH | 8/6/2025 | $31,930 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 000 | 8 | NIH | 3/3/2025 | $287,372 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 4 | NIH | 2/13/2025 | $473,813 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 001 | 4 | NIH | 5/22/2025 | $52,646 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 001 | 3 | NIH | 6/10/2025 | $288,581 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 000 | 3 | NIH | 3/20/2025 | $3,246,532 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA297561 | rRNA modification, ribosome composition and specialized translation in glioblastoma. | 000 | 1 | NIH | 7/23/2025 | $404,972 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM160303 | Molecular Architecture and Function of synaptic AMPA receptor complexes | 000 | 1 | NIH | 8/6/2025 | $385,639 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH125979 | Gene editing in the brain with CRISPR-PEG | 000 | 5 | NIH | 2/13/2025 | $567,518 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH125979 | Gene editing in the brain with CRISPR-PEG | 001 | 5 | NIH | 9/18/2025 | $100,150 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | S10OD038331 | 10x Genomics Xenium Analyzer | 000 | 1 | NIH | 7/7/2025 | $1 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R03DE034049 | Targeting TRPC1: A Novel Approach to Treat Oral Cancer | 000 | 1 | NIH | 8/20/2025 | $315,000 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | S10OD038331 | 10x Genomics Xenium Analyzer | 000 | 1 | NIH | 7/7/2025 | $364,999 |
|
